Morganella
Morganella is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
MICROBIOLOGY
- Facultative anaerobic Gram-negative rod.
- Morganella only has a single member in its genus M. morganii, and two subspecies: M. morganii and M. sibonii, which differ only in trehalose fermentation.
- Antimicrobial susceptibility:
- Naturally resistant to penicillin, ampicillin, first-, second-generation cephalosporins, fosfomycin, macrolides.
- Beta-lactamase is inducible, AmpC type but less commonly seen than with Enterobacter, Serratia.
- Production of extended-spectrum beta-lactamases, including carbapenemases Amber class B -such as New Delhi metallo-β-lactamase 1 (NDM-1)- and Amber class D -such as OXA-181- as well as fluoroquinolone resistance have been reported.
- Tigecycline is not reliably effective due to ArcAB efflux pump, although may show synergy in vitro with other antimicrobials[8].
-- To view the remaining sections of this topic, please log in or purchase a subscription --
MICROBIOLOGY
- Facultative anaerobic Gram-negative rod.
- Morganella only has a single member in its genus M. morganii, and two subspecies: M. morganii and M. sibonii, which differ only in trehalose fermentation.
- Antimicrobial susceptibility:
- Naturally resistant to penicillin, ampicillin, first-, second-generation cephalosporins, fosfomycin, macrolides.
- Beta-lactamase is inducible, AmpC type but less commonly seen than with Enterobacter, Serratia.
- Production of extended-spectrum beta-lactamases, including carbapenemases Amber class B -such as New Delhi metallo-β-lactamase 1 (NDM-1)- and Amber class D -such as OXA-181- as well as fluoroquinolone resistance have been reported.
- Tigecycline is not reliably effective due to ArcAB efflux pump, although may show synergy in vitro with other antimicrobials[8].
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 27, 2019
Citation
Fabre, Valeria. "Morganella." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540354/0/Morganella.
Fabre V. Morganella. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540354/0/Morganella. Accessed January 31, 2023.
Fabre, V. (2019). Morganella. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540354/0/Morganella
Fabre V. Morganella [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2023 January 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540354/0/Morganella.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Morganella
ID - 540354
A1 - Fabre,Valeria,M.D.
Y1 - 2019/09/27/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540354/0/Morganella
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -